Adipotide
$30.00
Adipotide (FTPP — Fat Targeted Peptide)
Description:
Adipotide, also known as FTPP (Fat Targeted Peptide), is a novel synthetic peptide designed to target and reduce adipose tissue by disrupting the blood supply to fat cells. It operates through a unique vascular targeting mechanism, distinguishing it from traditional metabolic or hormonal fat-loss agents. Adipotide has been studied for its potential to induce apoptosis (cell death) in fat cells, resulting in reduced adiposity and improved metabolic parameters without directly stimulating the central nervous system.
Key Benefits:
Promotes selective fat reduction through vascular targeting
Decreases white adipose tissue mass in animal studies
Improves insulin sensitivity and metabolic balance
Supports weight management and obesity research
Acts independently of appetite or hormonal modulation
Mechanism of Action:
Adipotide is a chimeric peptide composed of a homing sequence (CKGGRAKDC) that binds to prohibitin, a protein expressed on the surface of adipose vasculature, linked to a pro-apoptotic sequence (D(KLAKLAK)₂). Upon binding, the peptide selectively induces apoptosis in the blood vessels that nourish fat cells, cutting off nutrient supply and leading to adipocyte resorption. This mechanism allows for targeted fat depletion while sparing lean tissue and muscle mass, making Adipotide a promising research candidate for metabolic and weight-loss studies.
Molecular Formula: C75H124N24O22
Molecular Weight: ~1796.9 g/mol
Sequence: CKGGRAKDC-GG-D(KLAKLAK)₂
Purity: ≥98% (HPLC)
Form: Lyophilized powder for reconstitution
Storage:
Store at −20°C. Protect from light, heat, and moisture. Once reconstituted, refrigerate (2–8°C) and use within 30 days.
Disclaimer:
For laboratory research use only. Not for human consumption.